Researchers at MIT have made a significant discovery regarding a gene mutation that may contribute to cognitive difficulties faced by individuals with schizophrenia. Their experiments on mice revealed that this mutation disrupts a crucial brain circuit responsible for adjusting beliefs based on new information.
The gene in question, known as grin2a, has been highlighted in extensive genetic research on schizophrenia. The findings suggest that interventions targeting this brain circuit could potentially alleviate some cognitive symptoms associated with the disorder.
According to Guoping Feng, a professor at MIT and a member of the Broad Institute, "If this circuit doesn't function properly, integrating new information becomes a challenge." He emphasizes that this circuit is likely a significant factor in the cognitive impairments that characterize schizophrenia.
Feng, along with Michael Halassa from Tufts University, co-authored the study published in Nature Neuroscience. The lead authors of the research include Tingting Zhou and Yi-Yun Ho, both affiliated with the McGovern Institute at MIT.
Understanding Genetic Factors in Schizophrenia
Schizophrenia exhibits a strong genetic basis, affecting approximately 1% of the general population. This risk escalates to 10% for those with a family member diagnosed with the condition and reaches 50% for identical twins.
At the Stanley Center for Psychiatric Research, scientists have identified over 100 gene variants associated with schizophrenia. Many of these variants reside in non-coding DNA regions, complicating their interpretation. To gain clearer insights, researchers employed whole-exome sequencing to focus on the protein-coding segments of the genome, analyzing approximately 25,000 sequences from schizophrenia patients against 100,000 control subjects.
Impact of the grin2a Mutation on Brain Function
In their research, the team engineered mice with the grin2a mutation, which is integral to the NMDA receptor, a key component activated by the neurotransmitter glutamate. Although direct symptoms of schizophrenia like hallucinations cannot be replicated in mice, the researchers studied related behaviors, particularly the challenges in processing new sensory information.
Past theories suggest that psychosis may stem from an impaired ability to revise beliefs with incoming sensory data. Zhou explains that while neurotypical brains can adjust their beliefs based on new information, individuals with schizophrenia tend to rely heavily on pre-existing beliefs, leading to a disconnect from reality.
Experimental Insights into Decision-Making
To investigate this further, Zhou designed a task for the mice to choose between two levers offering different rewards. Healthy mice adapted their choices as conditions changed, while those with the grin2a mutation displayed slower decision-making, struggling to commit to the more rewarding option.
Identifying the Affected Brain Circuit
Using advanced imaging techniques, researchers pinpointed the mediodorsal thalamus as the brain region most impacted by the mutation. This area is crucial for decision-making and executive function, linking to the prefrontal cortex.
Remarkably, the team demonstrated that activating specific neurons within this circuit could reverse the behavioral effects of the mutation, suggesting potential pathways for therapeutic interventions in cognitive impairments associated with schizophrenia.
Future Implications
This research, supported by various institutions including the National Institutes of Mental Health, opens new avenues for treatment strategies targeting cognitive dysfunction in schizophrenia. As researchers continue to explore this circuit, the potential to enhance the quality of life for those affected by this condition becomes increasingly promising.
